We previously reported the rapid and robust clinical effects of ketamine versus saline infusions in a proof-of-concept crossover trial in unmedicated adults with obsessive-compulsive disorder (OCD). This study examined the concurrent neurochemical effects of ketamine versus saline infusions using proton magnetic resonance spectroscopy ( 1 H MRS) during the clinical proof-of-concept crossover trial. Levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and the excitatory neurochemicals glutamateþglutamine (Glx) were acquired in the medial prefrontal cortex (MPFC), a region implicated in OCD pathology. Seventeen unmedicated OCD adults received two intravenous infusions at least 1 week apart, one of saline and one of ketamine, while lying supine in a 3.0T GE MR scanner. The order of each infusion pair was randomized. Levels of GABA and Glx were measured in the MPFC before, during, and after each infusion and normalized to water (W). A mixed effects model found that MPFC GABA/W significantly increased over time in the ketamine compared with the saline infusion. In contrast, there were no significant differences in Glx/W between the ketamine and saline infusions. Together with earlier evidence of low cortical GABA in OCD, our findings suggest that models of OCD pathology should consider the role of GABAergic abnormalities in OCD symptomatology.
a b s t r a c t
We previously reported the rapid and robust clinical effects of ketamine versus saline infusions in a proof-of-concept crossover trial in unmedicated adults with obsessive-compulsive disorder (OCD). This study examined the concurrent neurochemical effects of ketamine versus saline infusions using proton magnetic resonance spectroscopy ( 1 H MRS) during the clinical proof-of-concept crossover trial. Levels of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) and the excitatory neurochemicals glutamateþglutamine (Glx) were acquired in the medial prefrontal cortex (MPFC), a region implicated in OCD pathology. Seventeen unmedicated OCD adults received two intravenous infusions at least 1 week apart, one of saline and one of ketamine, while lying supine in a 3.0T GE MR scanner. The order of each infusion pair was randomized. Levels of GABA and Glx were measured in the MPFC before, during, and after each infusion and normalized to water (W). A mixed effects model found that MPFC GABA/W significantly increased over time in the ketamine compared with the saline infusion. In contrast, there were no significant differences in Glx/W between the ketamine and saline infusions. Together with earlier evidence of low cortical GABA in OCD, our findings suggest that models of OCD pathology should consider the role of GABAergic abnormalities in OCD symptomatology.
& 2015 Elsevier Ireland Ltd. All rights reserved.
Introduction
Obsessive-compulsive disorder (OCD) is associated with dysfunction in fronto-striatal circuits (Maia et al., 2008; Ahmari et al., 2013; Burguiere et al., 2013) , and is characterized by repetitive thoughts (obsessions) and behaviors (compulsions) (Koran et al., 2007) . Treatment of OCD with serotonin reuptake inhibitors (SRIs) results in a long lag time (2-3 months) before clinical benefit that is typically only partially effective (Pigott and Seay, 1999; Dougherty et al., 2004) . Moreover, the only evidence-based medication strategy for augmenting SRIs in OCD is the addition of antipsychotics; however, this is effective in only one third of patients (Bloch et al., 2006) . Identifying pharmacological treatments beyond SRIs may not only advance therapeutic options, but also open new hypotheses regarding the mechanisms underlying OCD psychopathology.
Converging lines of evidence from in vivo brain-imaging, genetic, and pharmacological studies implicate abnormalities of glutamate, the most abundant excitatory neurotransmitter, in the pathogenesis of OCD (Pittenger et al., 2011) . Recently, we showed that a single subanesthetic dose of the glutamatergic N-methyl-Daspartate receptor antagonist ketamine rapidly and robustly reduces OCD symptoms in the absence of an SRI (Rodriguez et al., 2013) , supporting the "glutamate hypothesis of OCD" originally proposed by Rosenberg et al. (2000) ; for review, see Pittenger et al., 2011 
